Cited by 267Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Molecular Determinants of Dysregulated GABAergic Gene Expression in the Prefrontal Cortex of Subjects with Schizophrenia

Mellios, Nikolaos, Huang, Hsien-Sung, Baker, Stephen P., Galdzicka, Marzena, Ginns, Edward, Akbarian, Schahram·2009·Biological Psychiatry

DOI 10.1016/j.biopsych.2008.11.019

Open this paper in CoChat — free account

Abstract

Background Prefrontal deficits in gamma-aminobutyric acid (GABA)ergic gene expression, including neuropeptide Y (NPY), somatostatin (SST), and parvalbumin (PV) messenger RNAs (mRNAs), have been reported for multiple schizophrenia cohorts. Preclinical models suggest that a subset of these GABAergic markers (NPY/SST) is regulated by brain-derived neurotrophic factor (BDNF), which in turn is under the inhibitory influence of small noncoding RNAs. However, it remains unclear if these mechanisms are important determinants for dysregulated NPY and SST expression in prefrontal cortex (PFC) of subjects with schizophrenia.Methods Using a postmortem case-control design, the association between BDNF protein, NPY/SST/PV mRNAs, and two BDNF-regulating microRNAs (miR-195 and miR-30a-5p) was determined in samples from the PFC of 20 schizophrenia and 20 control subjects. Complementary studies were conducted in cerebral cortex of mice subjected to antipsychotic treatment or a brain-specific ablation of the Bdnf gene.Results Subjects with schizophrenia showed deficits in NPY and PV mRNAs. Within-pair differences in BDNF protein levels showed strong positive correlations with NPY and SST and a robust inverse association with miR-195 levels, which in turn were not affected by antipsychotic treatment or genetic ablation of Bdnf.Conclusions Taken together, these results suggest that prefrontal deficits in a subset of GABAergic mRNAs, including NPY, are dependent on the regional supply of BDNF, which in turn is fine-tuned through a microRNA (miRNA)-mediated mechanism.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2008.11.019

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Untitled work
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400
Decrease in Reelin and Glutamic Acid Decarboxylase67 (GAD67) Expression in Schizophrenia and Bipolar Disorder
Guidotti, A., Auta, J., Davis, J. M., Gerevini, V. D. G., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G. N., Pesold, C., Sharma, R. P., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1061 · Cited by 1,222
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database
Allen, N. C., Bagade, S., McQueen, M. B., Ioannidis, J. P. A., Kavvoura, F. K., Khoury, M. J., Tanzi, R. E., & Bertram, L. (2008) · Nature Genetics · doi:10.1038/ng.171 · Cited by 1,054
High rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Self-citation

Show all 47 references

Sorted by citations

Items 101–200 of 267

Expression of Transcripts Selective for GABA Neuron Subpopulations across the Cortical Visuospatial Working Memory Network in the Healthy State and Schizophrenia
Tsubomoto, M., Kawabata, R., Zhu, X., Minabe, Y., Chen, K., Lewis, D. A., & Hashimoto, T. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy227 · Cited by 54
Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia
Hagihara, H., Ohira, K., Takao, K., & Miyakawa, T. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-41 · Cited by 52
Age-Related Increase in the Number of Oligodendrocytes Is Dysregulated in Schizophrenia and Mood Disorders
Vm, V., & Uranova, N. A. (2011) · Schizophrenia Research and Treatment · doi:10.1155/2011/174689 · Cited by 51
How the epigenome contributes to the development of psychiatric disorders
Bredy, T. W., Sun, Y. E., & Kobor, M. S. (2010) · Developmental Psychobiology · doi:10.1002/dev.20424 · Cited by 51
Cortical Opioid Markers in Schizophrenia and across Postnatal Development
Volk, D. W., Radchenkova, P., Er, W., Sengupta, E. J., & Lewis, D. A. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr202 · Cited by 51
Cortical parvalbumin and somatostatin GABA neurons express distinct endogenous modulators of nicotinic acetylcholine receptors
Demars, M. P., & Morishita, H. (2014) · Molecular Brain · doi:10.1186/s13041-014-0075-9 · Cited by 54
Schizophrenia and neurogenesis: A stem cell approach
Iannitelli, A., Quartini, A., Tirassa, P., & Bersani, G. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.010 · Cited by 52
MicroRNAs and Child Neuropsychiatric Disorders: A Brief Review
Paul, S., Reyes‐Pérez, P., Garza, B. S., & Sharma, A. K. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02917-y · Cited by 48
Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia
Purves-Tyson, T. D., Brown, A. M., Weissleder, C., Rothmond, D. A., & Weickert, C. S. (2021) · Molecular Brain · doi:10.1186/s13041-021-00805-7 · Cited by 47
MicroRNAs in Neurotoxicity
Kaur, P., Armugam, A., & Jeyaseelan, K. (2012) · Journal of Toxicology · doi:10.1155/2012/870150 · Cited by 48
MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Zhang, H.-C., Du, Y., Chen, L., Yuan, Z., & Cheng, Y. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105064 · Cited by 47
Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia
Volk, D. W. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.019 · Cited by 47
Environmental enrichment or selective activation of parvalbumin-expressing interneurons ameliorates synaptic and behavioral deficits in animal models with schizophrenia-like behaviors during adolescence
Huang, Y., Jiang, H., Zheng, Q., Fok, A. H. K., Li, X., Lau, C. G., & Lai, C. S. W. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-01005-w · Cited by 47
Age‐dependent loss of parvalbumin‐expressing hippocampal interneurons in mice deficient in CHL 1, a mental retardation and schizophrenia susceptibility gene
Schmalbach, B., Lepsveridze, E., Djogo, N., Papashvili, G., Kuang, F., Leshchyns’ka, I., Sytnyk, V., Nikonenko, A. G., Dityatev, A. E., Jakovčevski, I., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13284 · Cited by 46
MiRNAs of peripheral blood as the biomarker of schizophrenia
He, K., Guo, C., He, L., & Shi, Y. (2017) · Hereditas · doi:10.1186/s41065-017-0044-2 · Cited by 46
Abnormal Brain-Derived Neurotrophic Factor Exon IX Promoter Methylation, Protein, and mRNA Levels in Patients with Major Depressive Disorder
Hsieh, M.-T., Lin, C.-C., Lee, C., & Huang, T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050568 · Cited by 47
Developmental co‐regulation of the β and γ GABAAreceptor subunits with distinct α subunits in the human dorsolateral prefrontal cortex
Fillman, S. G., Duncan, C. E., Webster, M. J., Elashoff, M., & Weickert, C. S. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.05.004 · Cited by 45
3q27.3 microdeletional syndrome: a recognisable clinical entity associating dysmorphic features, marfanoid habitus, intellectual disability and psychosis with mood disorder
Thévenon, J., Callier, P., Poquet, H., Bache, I., Menten, B., Malan, V., Cavaliere, M. L., Girod, J., Thauvin‐Robinet, C., Chehadeh, S. E., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101939 · Cited by 45
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis
Chana, G., Bousman, C., Money, T., Gibbons, A. S., Gillett, P., Dean, B., & Everall, I. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00095 · Cited by 44
Heterogeneity and Individuality: microRNAs in Mental Disorders
Hommers, L. G., Domschke, K., & Deckert, J. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1338-4 · Cited by 45
When less is more – microRNAs and psychiatric disorders
Kolshus, E., Dalton, V. S., Ryan, K. M., & McLoughlin, D. M. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12191 · Cited by 44
Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia
Volk, D. W., Edelson, J. R., & Lewis, D. A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.03.001 · Cited by 45
The Role of microRNAs in Drug Addiction
Pietrzykowski, A. Z. (2010) · International review of neurobiology · doi:10.1016/s0074-7742(10)91001-5 · Cited by 44
Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia
Sabaie, H., Moghaddam, M. M., Moghaddam, M. M., Ahangar, N. K., Asadi, M. R., Hussen, B. M., Taheri, M. N., & Rezazadeh, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-03993-3 · Cited by 43
Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology
Catts, V. S., & Weickert, C. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035511 · Cited by 43
The molecular pathology of schizophrenia—Focus on histone and DNA modifications
Akbarian, S. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.018 · Cited by 45
Self-citation
Growth factors stimulate expression of neuronal and glial miR-132
Numakawa, T., Yamamoto, N., Chiba, S., Richards, M., Ooshima, Y., Kishi, S., Hashido, K., Adachi, N., & Kunugi, H. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.10.025 · Cited by 43
Neuronal Development-Related miRNAs as Biomarkers for Alzheimer's Disease, Depression, Schizophrenia and Ionizing Radiation Exposure
Segaran, R. C., Chan, L. Y., Wang, H., Sethi, G., & Tang, F. R. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200121122910 · Cited by 42
Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia
Morishita, H., Kundakovic, M., Bicks, L., Mitchell, A., & Akbarian, S. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.03.005 · Cited by 42
Self-citation
Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats
Luoni, A., Hulsken, S., Cazzaniga, G., Racagni, G., Homberg, J. R., & Riva, M. A. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001332 · Cited by 42
Epigenetic and post-transcriptional dysregulation of gene expression in schizophrenia and related disease
Gavin, D. P., & Akbarian, S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.008 · Cited by 42
Self-citation
Elevated Viral Restriction Factor Levels in Cortical Blood Vessels in Schizophrenia
Siegel, B. I., Sengupta, E. J., Edelson, J. R., Lewis, D. A., & Volk, D. W. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.019 · Cited by 42
Chemokine receptors and cortical interneuron dysfunction in schizophrenia
Volk, D. W., Chitrapu, A., Edelson, J. R., & Lewis, D. A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.031 · Cited by 41
Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-16
Sun, Y., Yang, J., Wang, P., Li, Y., Xie, S., & Sun, R.-P. (2013) · Oncology Reports · doi:10.3892/or.2013.2731 · Cited by 41
Altered expression of microRNA-223 in the plasma of patients with first-episode schizophrenia and its possible relation to neuronal migration-related genes
Zhao, Z., Jinde, S., Koike, S., Tada, M., Satomura, Y., Yoshikawa, A., Nishimura, Y., Takizawa, R., Kinoshita, A., Sakakibara, E., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0609-0 · Cited by 42
The microRNA-195 - BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure
Pan, S., Feng, W., Li, Y., Huang, J., Chen, S., Cui, Y., Tian, B., Tan, S., Wang, Z., Yao, S., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01240-x · Cited by 41
MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field
Dinan, T. G. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990800 · Cited by 38
Alterations in a Unique Class of Cortical Chandelier Cell Axon Cartridges in Schizophrenia
Rocco, B. R., DeDionisio, A. M., Lewis, D. A., & Fish, K. N. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.018 · Cited by 39
Brain-Derived Neurotrophic Factor ( BDNF ) Epigenomic Modifications and Brain-Related Phenotypes in Humans: A Systematic Review
Treble‐Barna, A., Heinsberg, L. W., Stec, Z., Breazeale, S., Davis, T. S., Kesbhat, A., Chattopadhyay, A., VonVille, H. M., Ketchum, A., Yeates, K. O., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105078 · Cited by 37
Olfactory Discrimination Training Up-Regulates and Reorganizes Expression of MicroRNAs in Adult Mouse Hippocampus
Smalheiser, N. R., Lugli, G., Lenon, A. L., Davis, J. M., Torvik, V. I., & Larson, J. (2009) · ASN NEURO · doi:10.1042/an20090055 · Cited by 37
microRNAs as novel biomarkers of schizophrenia (Review)
Wang, J., Wang, Y., YANG, J., & Huang, Y. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2014 · Cited by 37
A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders
Abdolahi, S., Zare-Chahoki, A., Noorbakhsh, F., & Gorji, A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02966-5 · Cited by 39
Genomics and Pharmacogenomics of Schizophrenia
Cacabelos, R., & Martínez‐Bouza, R. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00187.x · Cited by 36
MicroRNA-7/Shank3 axis involved in schizophrenia pathogenesis
Zhang, J., Sun, X., & Zhang, L.-Y. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.01.031 · Cited by 36
BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study
Strube, W., Nitsche, M. A., Wobrock, T., Bunse, T., Rein, B., Herrmann, M., Schmitt, A., Nieratschker, V., Witt, S. H., Rietschel, M., et al. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu040 · Cited by 35
The prefrontal cortex as a target for atypical antipsychotics in schizophrenia, lessons of neurodevelopmental animal models
Tendilla‐Beltrán, H., Sanchez-Islas, N. D. C., Marina-Ramos, M., Leza, J. C., & Flores, G. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101967 · Cited by 36
Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia: A systematic review.
Cui, H., Jin, Y., Wang, J., Weng, X., & Li, C. (2012) · PubMed Central · doi:10.3969/j.issn.1002-0829.2012.05.002 · Cited by 33
Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics
Lis, M., Stańczykiewicz, B., Liśkiewicz, P., & Misiak, B. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104744 · Cited by 34
Stress Exposure in Dopamine D4 Receptor Knockout Mice Induces Schizophrenia-Like Behaviors via Disruption of GABAergic Transmission
Tan, T., Wang, W., Williams, J., Ma, K., Cao, Q., & Yan, Z. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby163 · Cited by 29
Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution
Dienel, S. J., Enwright, J. F., Hoftman, G. D., & Lewis, D. A. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.003 · Cited by 34
Aberrant Middle Prefrontal-Motor Cortex Connectivity Mediates Motor Inhibitory Biomarker in Schizophrenia
Du, X. M., Choa, F., Chiappelli, J., Wisner, K., Wittenberg, G. F., Adhikari, B. M., Bruce, H. A., Rowland, L. M., Kochunov, P. V., & Hong, L. E. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.06.007 · Cited by 31
Turning the ′Tides on Neuropsychiatric Diseases: The Role of Peptides in the Prefrontal Cortex
Brockway, D. F., & Crowley, N. A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.588400 · Cited by 30
Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia
Sommer, J. U., Schmitt, A., Heck, M., Schaeffer, E. L., Fendt, M., Zink, M., Nieselt, K., Symons, S., Petroianu, G. A., Lex, A., et al. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0159-1 · Cited by 31
Animal Models of Schizophrenia
Yanagi, M., Southcott, S. A., Lister, J. M., & Tamminga, C. A. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00012-3 · Cited by 32
Neural and neuronal discoordination in schizophrenia: from ensembles through networks to symptoms
Krajcovic, B., Fajnerova, I., Horacek, J., Kelemen, E., Kubik, S., Svoboda, J., & Stuchlik, A. (2019) · Acta Physiologica · doi:10.1111/apha.13282 · Cited by 29
Small non-coding RNA expression from anterior cingulate cortex in schizophrenia shows sex specific regulation
Ragan, C., Patel, K., Edson, J., Zhang, Z. H., Gratten, J., & Mowry, B. J. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.11.024 · Cited by 27
Transcriptomic immaturity inducible by neural hyperexcitation is shared by multiple neuropsychiatric disorders
Murano, T., Hagihara, H., Tajinda, K., Matsumoto, M., & Miyakawa, T. (2019) · Communications Biology · doi:10.1038/s42003-018-0277-2 · Cited by 26
Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study
Schmitt, A., Tatsch, L., Vollhardt, A., Schneider-Axmann, T., Raabe, F. J., Roell, L., Heinsen, H., Hof, P. R., Falkai, P., & Schmitz, C. (2022) · Cells · doi:10.3390/cells11203242 · Cited by 27
Genomics of schizophrenia and pharmacogenomics of antipsychotic drugs
Cacabelos, R., Cacabelos, P., & Aliev, G. (2013) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2013.31008 · Cited by 28
Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population
Ding, S., Chen, B., Zheng, Y., Lu, Q., Liu, L., & Zhuge, Q. C. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-107 · Cited by 27
Mapping miRNA Research in Schizophrenia: A Scientometric Review
Lim, M., Carollo, A., Neoh, M. J. Y., & Esposito, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010436 · Cited by 26
NPY mRNA expression in the prefrontal cortex: Selective reduction in the superficial white matter of subjects with schizoaffective disorder
Morris, H. M., Stopczynski, R. E., & Lewis, D. A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.09.014 · Cited by 27
Cortical Inhibitory Neuron Disturbances in Schizophrenia: Role of the Ontogenetic Transcription Factor Lhx6
Volk, D. W., Edelson, J. R., & Lewis, D. A. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu068 · Cited by 26
Reduced d-serine levels drive enhanced non-ionotropic NMDA receptor signaling and destabilization of dendritic spines in a mouse model for studying schizophrenia
Park, D. K., Petshow, S., Anisimova, M., Barragan, E. V., Gray, J. A., Stein, I. S., & Zito, K. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105772 · Cited by 24
Differential correlation of serum BDNF and microRNA content in rats with rapid or late onset of heavy alcohol use
Ehinger, Y., Phamluong, K., Darevesky, D., Welman, M., Moffat, J. J., Sakhai, S. A., Whiteley, E. L., Berger, A. L., Laguesse, S., Farokhnia, M., et al. (2020) · Addiction Biology · doi:10.1111/adb.12890 · Cited by 27
Evidence for Decreased Density of Calretinin-Immunopositive Neurons in the Caudate Nucleus in Patients With Schizophrenia
Adorján, I., Sun, B., Feher, V., Tyler, T., Veres, D. S., Chance, S. A., & Szele, F. G. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.581685 · Cited by 24
Non-coding RNAs and their bioengineering applications for neurological diseases
Das, T., Das, T. K., Khodarkovskaya, A., & Dash, S. (2021) · Bioengineered · doi:10.1080/21655979.2021.2003667 · Cited by 24
Potential diagnostic biomarkers for schizophrenia
Yue, W., Huang, H., & Duan, J. (2022) · Medical Review · doi:10.1515/mr-2022-0009 · Cited by 24
Self-citation
Identifying the differentially expressed peripheral blood microRNAs in psychiatric disorders: a systematic review and meta-analysis
Liu, X., Dong, L., Jiang, Z., Song, M., & Yan, P. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1390366 · Cited by 26
Similarities and differences of functional connectivity in drug-naïve, first-episode adolescent and young adult with major depressive disorder and schizophrenia
Wei, S., Womer, F. Y., Geng, H., Jiang, X., Zhou, Q., Chang, M., Zhou, Y., Tang, Y., & Wang, F. (2017) · Scientific Reports · doi:10.1038/srep44316 · Cited by 24
Age-dependent decrease of GAD65/67 mRNAs but normal densities of GABAergic interneurons in the brain regions of Shank3 -overexpressing manic mouse model
Lee, B., Zhang, Y., Kim, Y., Kim, S., Lee, Y., & Han, K. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.04.016 · Cited by 26
Profiles of VGF Peptides in the Rat Brain and Their Modulations after Phencyclidine Treatment
Noli, B., Sanna, F., Brancia, C., D’Amato, F., Manconi, B., Vincenzoni, F., Messana, I., Melis, M. R., Argiolas, A., Ferri, G., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00158 · Cited by 24
Increased excitation-inhibition balance and loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction
Jami, S. A., Cameron, S., Wong, J. M., Daly, E. R., McAllister, A. K., & Gray, J. A. (2021) · Journal of Neurophysiology · doi:10.1152/jn.00661.2020 · Cited by 25
Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia
Kimoto, S., Glausier, J. R., Fish, K. N., Volk, D. W., Bazmi, H. H., Arion, D., Datta, D., & Lewis, D. A. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv139 · Cited by 23
BDNF Modulation by microRNAs: An Update on the Experimental Evidence
de Assis, G. G., & Murawska‐Ciałowicz, E. (2024) · Cells · doi:10.3390/cells13100880 · Cited by 27
Sex difference in cognitive impairment in drug-free schizophrenia: Association with miR-195 levels
Huang, X., Bao, C., Lv, Q., Zhao, J., Wang, Y., Lang, X., Li, Z., & Yi, Z. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104748 · Cited by 22
Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons
Georgiev, D. D., Yoshihara, T., Kawabata, R., Matsubara, T., Tsubomoto, M., Minabe, Y., Lewis, D. A., & Hashimoto, T. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw022 · Cited by 23
Diagnostic Specificity and Association With Cognition of Molecular Alterations in Prefrontal Somatostatin Neurons in Schizophrenia
Dienel, S. J., Dowling, K. F., Barile, Z. J., Bazmi, H. H., Liu, A. Y., Vespoli, J. C., Fish, K. N., & Lewis, D. A. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.2972 · Cited by 25
The Potential of Cerebrolysin in the Treatment of Schizophrenia
Flores, G., & Atzori, M. (2014) · Pharmacology & Pharmacy · doi:10.4236/pp.2014.57079 · Cited by 21
Antipsychotic Subtypes Can be Characterized By Differences in their Ability to Modify Gabaergic Promoter Methylation
Dong, E., Grayson, D. R., Guidotti, A., & Costa, E. (2009) · Epigenomics · doi:10.2217/epi.09.2 · Cited by 21
Dysregulation of auditory neuroplasticity in schizophrenia
Voss, P., Thomas, M. E., Guercio, G. D., & de Villers‐Sidani, E. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.04.025 · Cited by 22
GABAergic dysfunction in postmortem dorsolateral prefrontal cortex: implications for cognitive deficits in schizophrenia and affective disorders
Hughes, H., Brady, L. J., & Schoonover, K. E. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1440834 · Cited by 20
LPS-induced inflammation reduces GABAergic interneuron markers and brain-derived neurotrophic factor in mouse prefrontal cortex and hippocampus
Rezaei, S., Prévot, T. D., Vieira, É. L. M., & Sibille, E. L. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100761 · Cited by 22
Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy
Hamamoto, O., Tirapelli, D. P. D. C., Neto, F. S. L., Freitas‐Lima, P., Saggioro, F. P., Cirino, M. L. D. A., Assirati, J. A., Serafini, L. N., Velasco, T. R., Sakamoto, A. C., et al. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.02.024 · Cited by 20
Blood-Based MicroRNAs in Psychotic Disorders—A Systematic Review
Grosu, Ș.-A., Dobre, M., Milanesi, E., & Hinescu, M. E. (2023) · Biomedicines · doi:10.3390/biomedicines11092536 · Cited by 19
Identification of Vulnerable Interneuron Subtypes in 15q13.3 Microdeletion Syndrome Using Single-Cell Transcriptomics
Malwade, S., Gasthaus, J., Bellardita, C., Andelic, M., Moric, B., Korshunova, I., Kiehn, O., Vasistha, N. A., & Khodosevich, K. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.09.012 · Cited by 18
Preterm Birth Alters the Maturation of the GABAergic System in the Human Prefrontal Cortex
Lacaille, H., Vacher, C., & Penn, A. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.827370 · Cited by 17
Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders
Zanardini, R., Ciani, M., Benussi, L., & Ghidoni, R. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00010 · Cited by 17
MicroRNA-195 predicts olanzapine response in drug-free patients with schizophrenia: A prospective cohort study
Huang, X., Bao, C., Lv, Q., Zhao, J., Hu, G., Wu, H., Li, Z., & Yi, Z. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120959617 · Cited by 15
5-HT2A Receptors and BDNF Regulation: Implications for Psychopathology
Jaggar, M., & Vaidya, V. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_17 · Cited by 15
Behavioral changes and brain epigenetic alterations induced by maternal deficiencies of B vitamins in a mouse model
Xu, P., Pang, D., Zhou, J., Li, S., Chen, D., & Yu, B. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05766-2 · Cited by 15
Alterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia
Lewis, D. A., & Glausier, J. R. (2016) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-30596-7_3 · Cited by 15
Neuropeptide Y as a possible homeostatic element for changes in cortical excitability induced by repetitive transcranial magnetic stimulation
Jazmati, D., Neubacher, U., & Funke, K. (2018) · Brain stimulation · doi:10.1016/j.brs.2018.02.017 · Cited by 13
MicroRNA’s impact on neurotransmitter and neuropeptide systems: small but mighty mediators of anxiety
Martinetz, S. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1814-9 · Cited by 12
Developmental dynamics of marmoset prefrontal cortical SST and PV interneuron networks highlight primate-specific features
Fin, N. A. S. H., Yip, A., Scott, J. T., Teo, L., Homman‐Ludiye, J., & Bourne, J. A. (2025) · Development · doi:10.1242/dev.204254 · Cited by 14
Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment
Yin, J., Lu, Y., Yu, S., Dai, Z., Zhang, F., & Yuan, J. (2020) · Hereditas · doi:10.1186/s41065-020-00158-6 · Cited by 11
Neuronal and glial 3D chromatin architecture illustrates cellular etiology of brain disordersPreprint
Hu, B., Won, H., Mah, W., Park, R., Kassim, B. S., Spiess, K., Kozlenkov, A., Crowley, C., Pochareddy, S., Li, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.14.096917 · Cited by 11
Self-citation
Cortical interneurons in schizophrenia – cause or effect?
Prkačin, M. V., Banovac, I., Petanjek, Z., & Hladnik, A. (2023) · Croatian Medical Journal · doi:10.3325/cmj.2023.64.110 · Cited by 12
Cerebralcare Granule® attenuates cognitive impairment in rats continuously overexpressing microRNA-30e
Xu, Y. J., Liu, Z., Song, X., Zhang, K., LI, X., Li, J., Xu, Y., Li, Y., Xie, Z., & Zhang, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4469 · Cited by 10
GABAergic and inflammatory changes in the frontal cortex following neonatal PCP plus isolation rearing, as a dual-hit neurodevelopmental model for schizophrenia
Cale, J. A., Chauhan, E. J., Cleaver, J. J., Fusciardi, A. R., McCann, S., Waters, H. C., Žavbi, J., & King, M. V. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03987-y · Cited by 9

Authors: Mellios, N., Huang, H.-S., Baker, S. P., Galdzicka, M., Ginns, E., & Akbarian, S.
Affiliations: University of Massachusetts Chan Medical School (US)
Corresponding author: Akbarian, Schahram
ORCID: Mellios, Nikolaos
Huang, Hsien-Sung
Baker, Stephen P.
Akbarian, Schahram
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2009-06
Volume: 65
Issue: 12
Pages: 1006-1014
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2008.11.019
OpenAlex: W1979089999
Cited by: 266
References: 47
Citations by year: 2026: 5 · 2025: 5 · 2024: 15 · 2023: 8 · 2022: 13 · 2021: 11 · 2020: 17 · 2019: 17 · 2018: 15 · 2017: 12 · 2016: 18 · 2015: 22 · 2014: 23 · 2013: 22 · 2012: 14
FWCI: 12.75
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
eScholarship@UMassChan (submittedVersion)
Funders: National Institute of Mental Health (R01MH081943, MH071476, MH081943, R01MH071476)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: schizophrenia, prefrontal cortex, neuropeptide Y, somatostatin, parvalbumin, brain-derived neurotrophic factor, miR-195, miR-30a-5p, microRNA regulation, antipsychotic drugs, BDNF knockout mice, postmortem brain
MeSH terms: Adult, Aged, Aged, 80 and over, Animals, Chromatin, gamma-Aminobutyric Acid, Gene Expression Regulation, Genotype, Humans, Immunoassay, Male, Mice, Inbred C57BL, Middle Aged, Neuropeptide Y, Parvalbumins, RNA, Schizophrenia, Somatostatin, Case-Control Studies, Prefrontal Cortex, Mice, Knockout, Brain-Derived Neurotrophic Factor, MicroRNAs, Immunoprecipitation, Mice, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular Determinants of Dysregulated GABAergic Gene Expression in the Prefrontal Cortex of Subjects with Schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks